Preventogen provides non-antibiotic infection prevention

Our FDA-cleared clinically proven polymer is ideal for preventing infection and promoting healing for closed surgical incisions, wounds, abrasions, and burns

FDA-CLEARED, CLASS I MEDICAL DEVICE

Kills all microbes

Eradicates all bacteria, fungi and viruses on contact​

Seals and Protects

Forms a biodegradable, water resistant protective barrier ​

optimizes healing

Optimizes the healing environment to help the body recover faster

Proven to kill the CDC's most serious threats

Preventogen has been proven to eradicate bacteria, fungi and viruses on contact

BACTERIA

Acinetobacter baumanii (multi-antibiotic resistant)

Campylobacter jejuni (drug-resistant)

Clostridioides difficile

Carbapenem-resistant Enterobacter cloacae

Cutibacterium acnes (Propionibacterium acnes) 

Enterococcus faecalis (drug-resistant)

Escherichia coli

MRSA: Methicillin-resistant Staphylococcus aureus

Mycobacterium avium

Neisseria gonorrhoeae (drug-resistant)

Pseudomonas aeruginosa

Shigella flexneri

Staphylococcus aureus

Streptococcus pneumoniae (drug-resistant)

Streptococcus pyogenes

VRE: Vancomycin-resistant Enterococci

FUNGI

Aspergillus brasiliensis

Candida albicans (drug-resistant)

Candida auris (antibiotic resistant)

Trichophyton mentagrophytes

Trichophyton rubrum

VIRUS

Herpes Simplex Virus Type 1

Monkeypox Virus (USA-2003)

Varicella Zoster Virus

Serious or Urgent threats as cited in the CDC’s Antibiotic Resistance Threats in the United States, 2019

Newest data

Clinically proven protection from pin-tract infections

Preventogen showed a statistically significant reduction in pin-tract infections

(P < 0.001)

PREVENTOGEN

n=60 pins
0 %

NO (0%) pin-tract infections

Control/standard of care

n=60 pins
0 %

14 (23%) pin-tract infections

Peer review

In a meta-analysis of 150 peer reviewed clinical studies involving 6,130 patients undergoing external fixation, the cumulative pin track infection rate was

0 %

How Preventogen can affect COVID-19